SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'BHM'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_A_STRA1_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 704ASN A 705LEU A 707GLN A 711MET A 742ARG A 752PHE A 891 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)None | 0.58A | 1a28A-2ax9A:34.7 | 1a28A-2ax9A:53.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_A_STRA1_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704LEU A 707GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 (-4.0A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 0.75A | 1a28A-2ax9A:34.7 | 1a28A-2ax9A:53.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_A_STRA1_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704LEU A 707GLN A 711MET A 742ARG A 752MET A 895 | BHM A 1 (-4.0A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)None | 0.96A | 1a28A-2ax9A:34.7 | 1a28A-2ax9A:53.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_B_STRB2_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 701LEU A 704ASN A 705LEU A 707GLN A 711MET A 742ARG A 752 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A) | 0.61A | 1a28B-2ax9A:34.7 | 1a28B-2ax9A:53.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_B_STRB2_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704LEU A 707GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 (-4.0A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 0.83A | 1a28B-2ax9A:34.7 | 1a28B-2ax9A:53.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_B_STRB2_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 707GLN A 711MET A 742ARG A 752MET A 895 | BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)None | 1.02A | 1a28B-2ax9A:34.7 | 1a28B-2ax9A:53.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EII_A_RTLA135_0 (CELLULARRETINOL-BINDINGPROTEIN II) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | ALA A 687ILE A 899THR A 877LEU A 880LEU A 700 | NoneNoneBHM A 1 (-3.0A)NoneNone | 1.37A | 1eiiA-2ax9A:undetectable | 1eiiA-2ax9A:18.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1GS4_A_ZK5A1918_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 10 / 12 | LEU A 704ASN A 705LEU A 707GLY A 708GLN A 711MET A 742VAL A 746MET A 780LEU A 880PHE A 891 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.3A)NoneNone | 0.58A | 1gs4A-2ax9A:40.8 | 1gs4A-2ax9A:99.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1GS4_A_ZK5A1918_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 704ASN A 705TRP A 741MET A 742VAL A 746MET A 780LEU A 880PHE A 891 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)NoneBHM A 1 ( 4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.3A)NoneNone | 1.03A | 1gs4A-2ax9A:40.8 | 1gs4A-2ax9A:99.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1GS4_A_ZK5A1918_2 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 4 / 5 | MET A 745MET A 749ARG A 752VAL A 889 | BHM A 1 (-3.9A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)None | 0.45A | 1gs4A-2ax9A:40.8 | 1gs4A-2ax9A:99.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IIU_A_RTLA176_0 (PLASMARETINOL-BINDINGPROTEIN) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 11 | LEU A 744ALA A 721ALA A 719LEU A 712GLN A 711 | NoneNoneNoneNoneBHM A 1 (-2.2A) | 1.12A | 1iiuA-2ax9A:undetectable | 1iiuA-2ax9A:20.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | ASN A 705GLY A 708GLN A 711MET A 742ARG A 752PHE A 891 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)None | 0.87A | 1m2zA-2ax9A:32.5 | 1m2zA-2ax9A:48.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 0.92A | 1m2zA-2ax9A:32.5 | 1m2zA-2ax9A:48.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | ASN A 705GLY A 708GLN A 711MET A 742ARG A 752PHE A 891 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)None | 0.80A | 1m2zD-2ax9A:32.6 | 1m2zD-2ax9A:48.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 0.95A | 1m2zD-2ax9A:32.6 | 1m2zD-2ax9A:48.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711MET A 745ARG A 752LEU A 873 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.9A)BHM A 1 (-3.8A)BHM A 1 (-4.4A) | 0.74A | 1nhzA-2ax9A:27.9 | 1nhzA-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 704ASN A 705GLY A 708GLN A 711MET A 745ARG A 752MET A 787 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.9A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 1.00A | 1nhzA-2ax9A:27.9 | 1nhzA-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 704ASN A 705LEU A 707GLY A 708GLN A 711MET A 742ARG A 752 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A) | 0.91A | 1p93A-2ax9A:31.8 | 1p93A-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 704LEU A 707GLY A 708GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 (-4.0A)BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 1.03A | 1p93A-2ax9A:31.8 | 1p93A-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | ASN A 705GLY A 708GLN A 711MET A 742ARG A 752PHE A 891 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)None | 0.85A | 1p93B-2ax9A:32.2 | 1p93B-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 0.93A | 1p93B-2ax9A:32.2 | 1p93B-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | ASN A 705GLY A 708GLN A 711MET A 742ARG A 752LEU A 873 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-4.4A) | 0.81A | 1p93C-2ax9A:31.6 | 1p93C-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 1.06A | 1p93C-2ax9A:31.6 | 1p93C-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | ASN A 705GLY A 708GLN A 711MET A 742ARG A 752PHE A 891 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)None | 0.91A | 1p93D-2ax9A:31.7 | 1p93D-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | GLY A 708GLN A 711MET A 742ARG A 752PHE A 764MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-4.4A)BHM A 1 (-3.6A) | 0.97A | 1p93D-2ax9A:31.7 | 1p93D-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | GLY A 708GLN A 711MET A 742ARG A 752PHE A 764PHE A 891 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-4.4A)None | 0.89A | 1p93D-2ax9A:31.7 | 1p93D-2ax9A:46.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RLB_E_REAE176_1 (RETINOL BINDINGPROTEIN) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 10 | LEU A 744ALA A 721ALA A 719LEU A 712GLN A 711 | NoneNoneNoneNoneBHM A 1 (-2.2A) | 1.07A | 1rlbE-2ax9A:undetectable | 1rlbE-2ax9A:19.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RLB_F_REAF177_1 (RETINOL BINDINGPROTEIN) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 11 | LEU A 744ALA A 721ALA A 719LEU A 712GLN A 711 | NoneNoneNoneNoneBHM A 1 (-2.2A) | 1.07A | 1rlbF-2ax9A:undetectable | 1rlbF-2ax9A:19.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S9P_C_DESC500_1 (ESTROGEN-RELATEDRECEPTOR GAMMA) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 701LEU A 704LEU A 707MET A 742ARG A 752 | NoneBHM A 1 (-4.0A)BHM A 1 ( 4.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A) | 0.59A | 1s9pC-2ax9A:26.4 | 1s9pC-2ax9A:27.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 701LEU A 704ASN A 705LEU A 707GLN A 711MET A 742MET A 745 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A) | 0.59A | 1sqnA-2ax9A:34.4 | 1sqnA-2ax9A:53.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 701LEU A 704ASN A 705LEU A 707LEU A 873 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-4.4A) | 1.44A | 1sqnA-2ax9A:34.4 | 1sqnA-2ax9A:53.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 701LEU A 704LEU A 707GLN A 711MET A 742MET A 745MET A 787 | NoneBHM A 1 (-4.0A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.6A) | 0.75A | 1sqnA-2ax9A:34.4 | 1sqnA-2ax9A:53.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 707GLN A 711MET A 742MET A 745MET A 895 | BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)None | 1.08A | 1sqnA-2ax9A:34.4 | 1sqnA-2ax9A:53.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 701LEU A 704ASN A 705LEU A 707GLN A 711MET A 742MET A 745LEU A 873 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-4.4A) | 0.73A | 1sqnB-2ax9A:34.7 | 1sqnB-2ax9A:53.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 707GLN A 711MET A 742MET A 745MET A 787LEU A 873 | BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.6A)BHM A 1 (-4.4A) | 1.10A | 1sqnB-2ax9A:34.7 | 1sqnB-2ax9A:53.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_A_STRA1001_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 701ASN A 705LEU A 707GLN A 711MET A 742ARG A 752MET A 780MET A 787 | NoneBHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-3.6A) | 0.74A | 1ya3A-2ax9A:34.8 | 1ya3A-2ax9A:51.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_B_STRB2001_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 701ASN A 705GLN A 711MET A 742ARG A 752MET A 780LEU A 873 | NoneBHM A 1 (-3.6A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-4.4A) | 0.81A | 1ya3B-2ax9A:35.0 | 1ya3B-2ax9A:51.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_C_STRC3001_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 701ASN A 705GLN A 711MET A 742ARG A 752MET A 780LEU A 873 | NoneBHM A 1 (-3.6A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-4.4A) | 0.96A | 1ya3C-2ax9A:34.8 | 1ya3C-2ax9A:51.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_C_STRC3001_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 701LEU A 704ASN A 705LEU A 707GLN A 711MET A 742ARG A 752MET A 780 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A) | 0.89A | 1ya3C-2ax9A:34.8 | 1ya3C-2ax9A:51.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z95_A_198A501_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 12 / 12 | LEU A 707GLY A 708GLN A 711MET A 742MET A 745VAL A 746MET A 749ARG A 752HIS A 874THR A 877MET A 895ILE A 899 | BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)NoneBHM A 1 (-3.0A)NoneNone | 0.40A | 1z95A-2ax9A:41.9 | 1z95A-2ax9A:99.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z95_A_198A501_2 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 6 | LEU A 704ASN A 705MET A 787LEU A 873ILE A 898 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 (-3.6A)BHM A 1 (-4.4A)None | 0.42A | 1z95A-2ax9A:41.9 | 1z95A-2ax9A:99.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_A_T98A201_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 10 | LEU A 701ASN A 705GLN A 711MET A 745ARG A 752PHE A 891 | NoneBHM A 1 (-3.6A)BHM A 1 (-2.2A)BHM A 1 (-3.9A)BHM A 1 (-3.8A)None | 0.58A | 1zucA-2ax9A:34.8 | 1zucA-2ax9A:54.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 9 / 12 | LEU A 701LEU A 704ASN A 705LEU A 707GLN A 711MET A 742MET A 745ARG A 752PHE A 891 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.8A)None | 0.63A | 1zucB-2ax9A:34.7 | 1zucB-2ax9A:54.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 701LEU A 704ASN A 705MET A 742PHE A 891 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.0A)None | 1.26A | 1zucB-2ax9A:34.7 | 1zucB-2ax9A:54.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_A_STRA301_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | ASN A 705LEU A 707GLN A 711MET A 742ARG A 752MET A 780MET A 787 | BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-3.6A) | 0.68A | 2aa5A-2ax9A:35.9 | 2aa5A-2ax9A:48.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_B_STRB302_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 701ASN A 705LEU A 707GLN A 711MET A 742ARG A 752MET A 780 | NoneBHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A) | 0.68A | 2aa5B-2ax9A:35.4 | 2aa5B-2ax9A:48.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_A_STRA401_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 704ASN A 705LEU A 707GLN A 711MET A 742ARG A 752MET A 780MET A 787 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-3.6A) | 0.69A | 2aa6A-2ax9A:35.8 | 2aa6A-2ax9A:48.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_B_STRB402_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | ASN A 705LEU A 707GLN A 711MET A 742ARG A 752MET A 780MET A 787LEU A 873 | BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-3.6A)BHM A 1 (-4.4A) | 0.77A | 2aa6B-2ax9A:35.6 | 2aa6B-2ax9A:48.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 9 / 12 | LEU A 701ASN A 705GLN A 711MET A 742ARG A 752PHE A 764MET A 780MET A 787PHE A 891 | NoneBHM A 1 (-3.6A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-4.4A)BHM A 1 ( 4.3A)BHM A 1 (-3.6A)None | 0.72A | 2ab2A-2ax9A:35.8 | 2ab2A-2ax9A:48.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 9 / 12 | LEU A 701ASN A 705GLN A 711MET A 742ARG A 752PHE A 764MET A 780MET A 787PHE A 891 | NoneBHM A 1 (-3.6A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-4.4A)BHM A 1 ( 4.3A)BHM A 1 (-3.6A)None | 0.71A | 2ab2B-2ax9A:35.7 | 2ab2B-2ax9A:48.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | ASN A 705LEU A 707GLN A 711MET A 745ARG A 752MET A 895 | BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 (-3.9A)BHM A 1 (-3.8A)None | 0.92A | 2am9A-2ax9A:41.3 | 2am9A-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 10 / 12 | ASN A 705LEU A 707MET A 742MET A 745MET A 749ARG A 752MET A 780LEU A 873THR A 877MET A 895 | BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-4.4A)BHM A 1 (-3.0A)None | 0.54A | 2am9A-2ax9A:41.3 | 2am9A-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | ASN A 705TRP A 741MET A 742MET A 780LEU A 873THR A 877MET A 895 | BHM A 1 (-3.6A)NoneBHM A 1 ( 4.0A)BHM A 1 ( 4.3A)BHM A 1 (-4.4A)BHM A 1 (-3.0A)None | 1.06A | 2am9A-2ax9A:41.3 | 2am9A-2ax9A:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EJT_A_SAMA501_0 (N(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASE) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 701ALA A 699ASN A 705SER A 888PHE A 876 | NoneNoneBHM A 1 (-3.6A)NoneNone | 1.19A | 2ejtA-2ax9A:undetectable | 2ejtA-2ax9A:21.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 9 / 12 | LEU A 701ASN A 705LEU A 707GLN A 711MET A 742ARG A 752MET A 780LEU A 873PHE A 891 | NoneBHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-4.4A)None | 0.77A | 2oaxA-2ax9A:35.2 | 2oaxA-2ax9A:51.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_B_SNLB2001_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 701ASN A 705LEU A 707GLN A 711MET A 742ARG A 752LEU A 873PHE A 891 | NoneBHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-4.4A)None | 0.64A | 2oaxB-2ax9A:35.4 | 2oaxB-2ax9A:51.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_C_SNLC3001_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 701ASN A 705GLN A 711MET A 742ARG A 752MET A 780LEU A 873PHE A 891 | NoneBHM A 1 (-3.6A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-4.4A)None | 0.72A | 2oaxC-2ax9A:35.8 | 2oaxC-2ax9A:51.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_C_SNLC3001_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 701ASN A 705TRP A 741MET A 742MET A 780LEU A 873PHE A 891 | NoneBHM A 1 (-3.6A)NoneBHM A 1 ( 4.0A)BHM A 1 ( 4.3A)BHM A 1 (-4.4A)None | 1.13A | 2oaxC-2ax9A:35.8 | 2oaxC-2ax9A:51.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_D_SNLD4001_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 9 / 12 | LEU A 701ASN A 705LEU A 707GLN A 711MET A 742ARG A 752MET A 780LEU A 873PHE A 891 | NoneBHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-4.4A)None | 0.72A | 2oaxD-2ax9A:35.3 | 2oaxD-2ax9A:51.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_D_SNLD4001_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 701ASN A 705TRP A 741MET A 742MET A 780LEU A 873PHE A 891 | NoneBHM A 1 (-3.6A)NoneBHM A 1 ( 4.0A)BHM A 1 ( 4.3A)BHM A 1 (-4.4A)None | 1.22A | 2oaxD-2ax9A:35.3 | 2oaxD-2ax9A:51.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_E_SNLE5001_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 701ASN A 705LEU A 707GLN A 711MET A 742ARG A 752LEU A 873PHE A 891 | NoneBHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-4.4A)None | 0.71A | 2oaxE-2ax9A:34.8 | 2oaxE-2ax9A:51.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_E_SNLE5001_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 701ASN A 705LEU A 707GLN A 711MET A 742ARG A 752MET A 780PHE A 891 | NoneBHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)None | 0.80A | 2oaxE-2ax9A:34.8 | 2oaxE-2ax9A:51.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_F_SNLF6001_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | ASN A 705LEU A 707GLN A 711MET A 742ARG A 752LEU A 873PHE A 891 | BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-4.4A)None | 0.73A | 2oaxF-2ax9A:34.6 | 2oaxF-2ax9A:51.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_F_SNLF6001_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | ASN A 705TRP A 741MET A 742LEU A 873PHE A 891 | BHM A 1 (-3.6A)NoneBHM A 1 ( 4.0A)BHM A 1 (-4.4A)None | 1.22A | 2oaxF-2ax9A:34.6 | 2oaxF-2ax9A:51.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 10 / 12 | LEU A 704ASN A 705LEU A 707GLY A 708GLN A 711VAL A 746ARG A 752MET A 780LEU A 880PHE A 891 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.6A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)NoneNone | 0.60A | 2oz7A-2ax9A:39.2 | 2oz7A-2ax9A:99.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 707GLY A 708GLN A 711VAL A 746ARG A 752LEU A 880MET A 895 | BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.6A)BHM A 1 (-3.8A)NoneNone | 0.96A | 2oz7A-2ax9A:39.2 | 2oz7A-2ax9A:99.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_2 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 4 / 6 | LEU A 880TRP A 741MET A 742MET A 787 | NoneNoneBHM A 1 ( 4.0A)BHM A 1 (-3.6A) | 1.29A | 2oz7A-2ax9A:39.2 | 2oz7A-2ax9A:99.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_2 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 4 / 6 | LEU A 880TRP A 741MET A 745MET A 787 | NoneNoneBHM A 1 (-3.9A)BHM A 1 (-3.6A) | 1.42A | 2oz7A-2ax9A:39.2 | 2oz7A-2ax9A:99.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_2 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 4 / 6 | TRP A 741MET A 742MET A 787LEU A 873 | NoneBHM A 1 ( 4.0A)BHM A 1 (-3.6A)BHM A 1 (-4.4A) | 0.30A | 2oz7A-2ax9A:39.2 | 2oz7A-2ax9A:99.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7I_A_TESA205_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 12 / 12 | LEU A 704ASN A 705LEU A 707GLN A 711MET A 742MET A 745VAL A 746MET A 749ARG A 752MET A 780THR A 877MET A 895 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-3.0A)None | 0.58A | 2q7iA-2ax9A:41.4 | 2q7iA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7J_A_TESA203_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 700LEU A 707GLN A 711MET A 749ARG A 752 | NoneBHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 (-4.3A)BHM A 1 (-3.8A) | 1.06A | 2q7jA-2ax9A:41.0 | 2q7jA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7J_A_TESA203_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 11 / 12 | LEU A 701ASN A 705LEU A 707GLN A 711MET A 742MET A 745MET A 749ARG A 752MET A 780THR A 877MET A 895 | NoneBHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-3.0A)None | 0.63A | 2q7jA-2ax9A:41.0 | 2q7jA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7J_A_TESA203_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 701ASN A 705TRP A 741MET A 742MET A 780THR A 877MET A 895 | NoneBHM A 1 (-3.6A)NoneBHM A 1 ( 4.0A)BHM A 1 ( 4.3A)BHM A 1 (-3.0A)None | 1.05A | 2q7jA-2ax9A:41.0 | 2q7jA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7K_A_TESA304_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 12 / 12 | LEU A 704ASN A 705LEU A 707GLN A 711MET A 742VAL A 746MET A 749ARG A 752MET A 780LEU A 873THR A 877MET A 895 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-4.4A)BHM A 1 (-3.0A)None | 0.55A | 2q7kA-2ax9A:41.7 | 2q7kA-2ax9A:99.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7L_A_TESA155_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 11 / 12 | LEU A 704ASN A 705LEU A 707GLY A 708GLN A 711MET A 742VAL A 746MET A 749ARG A 752MET A 780THR A 877 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-3.0A) | 0.47A | 2q7lA-2ax9A:41.2 | 2q7lA-2ax9A:99.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7L_A_TESA155_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 704ASN A 705TRP A 741MET A 742VAL A 746MET A 780THR A 877 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)NoneBHM A 1 ( 4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.3A)BHM A 1 (-3.0A) | 1.07A | 2q7lA-2ax9A:41.2 | 2q7lA-2ax9A:99.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 700LEU A 707GLY A 708GLN A 711ARG A 752 | NoneBHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.8A) | 1.38A | 2w8yA-2ax9A:34.7 | 2w8yA-2ax9A:53.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 701LEU A 707GLY A 708GLN A 711MET A 742MET A 745ARG A 752 | NoneBHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.8A) | 0.55A | 2w8yA-2ax9A:34.7 | 2w8yA-2ax9A:53.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 4 / 7 | LEU A 704ASN A 705GLU A 709LEU A 712 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)NoneNone | 0.53A | 2w8yA-2ax9A:34.7 | 2w8yA-2ax9A:53.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 701LEU A 704ASN A 705LEU A 707GLN A 711MET A 742MET A 745ARG A 752 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.8A) | 0.55A | 2w8yB-2ax9A:34.7 | 2w8yB-2ax9A:53.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 701LEU A 704ASN A 705LEU A 707LEU A 873 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-4.4A) | 1.49A | 2w8yB-2ax9A:34.7 | 2w8yB-2ax9A:53.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 701LEU A 704LEU A 707GLN A 711MET A 742MET A 745ARG A 752MET A 787 | NoneBHM A 1 (-4.0A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 0.80A | 2w8yB-2ax9A:34.7 | 2w8yB-2ax9A:53.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YHD_A_TESA1920_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 700LEU A 707GLN A 711MET A 749ARG A 752 | NoneBHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 (-4.3A)BHM A 1 (-3.8A) | 1.06A | 2yhdA-2ax9A:40.1 | 2yhdA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YHD_A_TESA1920_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 12 / 12 | LEU A 701ASN A 705LEU A 707GLY A 708GLN A 711MET A 742MET A 745MET A 749ARG A 752MET A 780THR A 877MET A 895 | NoneBHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-3.0A)None | 0.56A | 2yhdA-2ax9A:40.1 | 2yhdA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YHD_A_TESA1920_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 880GLY A 708MET A 742MET A 745MET A 895 | NoneBHM A 1 ( 3.8A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)None | 1.35A | 2yhdA-2ax9A:40.1 | 2yhdA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLO_A_TESA1920_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 10 / 12 | LEU A 704ASN A 705LEU A 707GLN A 711MET A 745VAL A 746MET A 749ARG A 752PHE A 891MET A 895 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 (-3.9A)BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)NoneNone | 0.72A | 2yloA-2ax9A:40.2 | 2yloA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLO_A_TESA1920_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 11 / 12 | LEU A 704ASN A 705LEU A 707MET A 742MET A 745VAL A 746MET A 749ARG A 752THR A 877PHE A 891MET A 895 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)BHM A 1 (-3.0A)NoneNone | 0.57A | 2yloA-2ax9A:40.2 | 2yloA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLP_A_TESA1921_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 11 | LEU A 700LEU A 707GLN A 711MET A 749ARG A 752 | NoneBHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 (-4.3A)BHM A 1 (-3.8A) | 1.05A | 2ylpA-2ax9A:40.5 | 2ylpA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLP_A_TESA1921_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 11 / 11 | LEU A 701ASN A 705LEU A 707GLN A 711MET A 742MET A 745MET A 749ARG A 752LEU A 873THR A 877MET A 895 | NoneBHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)BHM A 1 (-4.4A)BHM A 1 (-3.0A)None | 0.53A | 2ylpA-2ax9A:40.5 | 2ylpA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLP_A_TESA1921_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 11 | LEU A 704ASN A 705LEU A 873THR A 877MET A 895 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 (-4.4A)BHM A 1 (-3.0A)None | 1.42A | 2ylpA-2ax9A:40.5 | 2ylpA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLQ_A_TESA1921_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 11 | LEU A 700LEU A 707GLN A 711MET A 749ARG A 752 | NoneBHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 (-4.3A)BHM A 1 (-3.8A) | 1.02A | 2ylqA-2ax9A:40.4 | 2ylqA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLQ_A_TESA1921_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 11 / 11 | LEU A 701ASN A 705LEU A 707GLN A 711MET A 742MET A 745VAL A 746MET A 749ARG A 752THR A 877MET A 895 | NoneBHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)BHM A 1 (-3.0A)None | 0.56A | 2ylqA-2ax9A:40.4 | 2ylqA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | ASN A 705GLY A 708GLN A 711MET A 742ARG A 752CYH A 784LEU A 873PHE A 891 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)NoneBHM A 1 (-4.4A)None | 0.86A | 3cldA-2ax9A:32.3 | 3cldA-2ax9A:48.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | ASN A 705GLY A 708GLN A 711MET A 742ARG A 752CYH A 784LEU A 873PHE A 891 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)NoneBHM A 1 (-4.4A)None | 0.88A | 3cldB-2ax9A:32.4 | 3cldB-2ax9A:48.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 701LEU A 704ASN A 705LEU A 707GLN A 711MET A 742MET A 745ARG A 752 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.8A) | 0.60A | 3d90A-2ax9A:34.1 | 3d90A-2ax9A:54.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 701LEU A 704LEU A 707GLN A 711MET A 742MET A 745ARG A 752MET A 787 | NoneBHM A 1 (-4.0A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 0.77A | 3d90A-2ax9A:34.1 | 3d90A-2ax9A:54.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_B_NOGB2001_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 701ASN A 705LEU A 707GLN A 711MET A 742ARG A 752 | NoneBHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A) | 0.70A | 3d90B-2ax9A:34.1 | 3d90B-2ax9A:54.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_B_NOGB2001_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704ASN A 705LEU A 707GLN A 711MET A 742ARG A 752 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A) | 0.58A | 3d90B-2ax9A:34.1 | 3d90B-2ax9A:54.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_B_NOGB2001_1 (PROGESTERONERECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 707GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 0.93A | 3d90B-2ax9A:34.1 | 3d90B-2ax9A:54.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 0.92A | 3gn8A-2ax9A:32.8 | 3gn8A-2ax9A:53.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704ASN A 705GLY A 708GLN A 711MET A 742VAL A 889 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)None | 0.95A | 3gn8A-2ax9A:32.8 | 3gn8A-2ax9A:53.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 704ASN A 705TRP A 741MET A 742VAL A 889 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)NoneBHM A 1 ( 4.0A)None | 1.44A | 3gn8A-2ax9A:32.8 | 3gn8A-2ax9A:53.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704GLY A 708GLN A 711MET A 742ARG A 752VAL A 889 | BHM A 1 (-4.0A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)None | 0.92A | 3gn8A-2ax9A:32.8 | 3gn8A-2ax9A:53.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 0.89A | 3gn8B-2ax9A:32.8 | 3gn8B-2ax9A:53.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 704ASN A 705GLY A 708GLN A 711MET A 742ARG A 752VAL A 889PHE A 891 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)NoneNone | 0.94A | 3gn8B-2ax9A:32.8 | 3gn8B-2ax9A:53.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | ASN A 705GLY A 708GLN A 711MET A 742ARG A 752LEU A 873 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-4.4A) | 0.69A | 3h52A-2ax9A:24.4 | 3h52A-2ax9A:48.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | GLY A 708GLN A 711MET A 742ARG A 752MET A 787LEU A 873 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A)BHM A 1 (-4.4A) | 1.12A | 3h52A-2ax9A:24.4 | 3h52A-2ax9A:48.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704ASN A 705GLY A 708GLN A 711MET A 742ARG A 752 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A) | 0.68A | 3h52A-2ax9A:24.4 | 3h52A-2ax9A:48.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704GLY A 708GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 (-4.0A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 1.00A | 3h52A-2ax9A:24.4 | 3h52A-2ax9A:48.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | GLY A 708GLN A 711ARG A 752CYH A 784MET A 787ILE A 898 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.8A)NoneBHM A 1 (-3.6A)None | 0.89A | 3h52B-2ax9A:25.8 | 3h52B-2ax9A:48.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | GLY A 708GLN A 711MET A 742ARG A 752PHE A 764MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-4.4A)BHM A 1 (-3.6A) | 0.92A | 3h52C-2ax9A:24.1 | 3h52C-2ax9A:48.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704GLY A 708GLN A 711ARG A 752PHE A 764MET A 787 | BHM A 1 (-4.0A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.8A)BHM A 1 (-4.4A)BHM A 1 (-3.6A) | 0.81A | 3h52C-2ax9A:24.1 | 3h52C-2ax9A:48.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711MET A 742ARG A 752LEU A 873 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-4.4A) | 0.67A | 3h52D-2ax9A:25.6 | 3h52D-2ax9A:48.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 1.07A | 3h52D-2ax9A:25.6 | 3h52D-2ax9A:48.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | ASN A 705GLY A 708GLN A 711MET A 742ARG A 752LEU A 873 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-4.4A) | 0.80A | 3mneA-2ax9A:31.0 | 3mneA-2ax9A:49.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | ASN A 705GLY A 708GLN A 711MET A 742LEU A 873PHE A 891 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-4.4A)None | 0.94A | 3mneA-2ax9A:31.0 | 3mneA-2ax9A:49.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | ASN A 705GLN A 711MET A 742ARG A 752LEU A 873 | BHM A 1 (-3.6A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-4.4A) | 0.83A | 3mnoA-2ax9A:31.6 | 3mnoA-2ax9A:49.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | ASN A 705GLN A 711MET A 742LEU A 873PHE A 891 | BHM A 1 (-3.6A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-4.4A)None | 0.96A | 3mnoA-2ax9A:31.6 | 3mnoA-2ax9A:49.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | ASN A 705GLY A 708GLN A 711MET A 742ARG A 752 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A) | 0.79A | 3mnoA-2ax9A:31.6 | 3mnoA-2ax9A:49.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | ASN A 705GLY A 708GLN A 711MET A 742PHE A 891 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)None | 0.89A | 3mnoA-2ax9A:31.6 | 3mnoA-2ax9A:49.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLN A 711MET A 742VAL A 746ARG A 752LEU A 873 | BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.6A)BHM A 1 (-3.8A)BHM A 1 (-4.4A) | 0.73A | 3mnoA-2ax9A:31.6 | 3mnoA-2ax9A:49.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711MET A 742VAL A 746ARG A 752 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.6A)BHM A 1 (-3.8A) | 0.60A | 3mnoA-2ax9A:31.6 | 3mnoA-2ax9A:49.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | ASN A 705GLN A 711MET A 742ARG A 752LEU A 873 | BHM A 1 (-3.6A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-4.4A) | 0.83A | 3mnpA-2ax9A:32.1 | 3mnpA-2ax9A:50.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | ASN A 705GLN A 711MET A 742LEU A 873PHE A 891 | BHM A 1 (-3.6A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-4.4A)None | 1.01A | 3mnpA-2ax9A:32.1 | 3mnpA-2ax9A:50.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | ASN A 705GLY A 708GLN A 711MET A 742ARG A 752 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A) | 0.78A | 3mnpA-2ax9A:32.1 | 3mnpA-2ax9A:50.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | ASN A 705GLY A 708GLN A 711MET A 742PHE A 891 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)None | 0.93A | 3mnpA-2ax9A:32.1 | 3mnpA-2ax9A:50.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLN A 711MET A 742VAL A 746ARG A 752LEU A 873 | BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.6A)BHM A 1 (-3.8A)BHM A 1 (-4.4A) | 0.73A | 3mnpA-2ax9A:32.1 | 3mnpA-2ax9A:50.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711MET A 742VAL A 746ARG A 752 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.6A)BHM A 1 (-3.8A) | 0.59A | 3mnpA-2ax9A:32.1 | 3mnpA-2ax9A:50.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VHU_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 701ASN A 705GLN A 711MET A 742ARG A 752MET A 780LEU A 873PHE A 891 | NoneBHM A 1 (-3.6A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-4.4A)None | 0.74A | 3vhuA-2ax9A:35.7 | 3vhuA-2ax9A:46.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ZQT_A_TESA1000_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 10 / 12 | LEU A 701LEU A 704ASN A 705LEU A 707GLN A 711MET A 745VAL A 746MET A 749ARG A 752MET A 895 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 (-3.9A)BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)None | 0.66A | 3zqtA-2ax9A:40.4 | 3zqtA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ZQT_A_TESA1000_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 11 / 12 | LEU A 701LEU A 704ASN A 705LEU A 707MET A 742MET A 745VAL A 746MET A 749ARG A 752THR A 877MET A 895 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)BHM A 1 (-3.0A)None | 0.52A | 3zqtA-2ax9A:40.4 | 3zqtA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FN9_A_STRA301_1 (STEROID RECEPTOR 2) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 701LEU A 704ASN A 705LEU A 707GLN A 711MET A 742ARG A 752MET A 780 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A) | 0.67A | 4fn9A-2ax9A:36.1 | 4fn9A-2ax9A:60.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FN9_B_STRB301_1 (STEROID RECEPTOR 2) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 701ASN A 705TRP A 741MET A 742MET A 780 | NoneBHM A 1 (-3.6A)NoneBHM A 1 ( 4.0A)BHM A 1 ( 4.3A) | 1.28A | 4fn9B-2ax9A:36.0 | 4fn9B-2ax9A:60.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FN9_B_STRB301_1 (STEROID RECEPTOR 2) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 9 / 12 | LEU A 701LEU A 704ASN A 705LEU A 707GLN A 711MET A 742MET A 749ARG A 752MET A 780 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A) | 0.67A | 4fn9B-2ax9A:36.0 | 4fn9B-2ax9A:60.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HLW_A_TESA1001_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 11 / 12 | LEU A 704ASN A 705GLY A 708GLN A 711MET A 742MET A 745VAL A 746MET A 749ARG A 752THR A 877MET A 895 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)BHM A 1 (-3.0A)None | 0.57A | 4hlwA-2ax9A:40.8 | 4hlwA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HLW_A_TESA1001_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 704ASN A 705TRP A 741MET A 742VAL A 746THR A 877MET A 895 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)NoneBHM A 1 ( 4.0A)BHM A 1 (-3.6A)BHM A 1 (-3.0A)None | 1.08A | 4hlwA-2ax9A:40.8 | 4hlwA-2ax9A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_1 (ANCESTRAL STEROIDRECEPTOR 2) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 9 / 12 | LEU A 701LEU A 704ASN A 705LEU A 707GLN A 711MET A 742ARG A 752MET A 780LEU A 873 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-4.4A) | 0.69A | 4ltwA-2ax9A:36.1 | 4ltwA-2ax9A:60.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_1 (ANCESTRAL STEROIDRECEPTOR 2) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 9 / 12 | LEU A 701LEU A 704LEU A 707GLN A 711MET A 742MET A 749ARG A 752MET A 780LEU A 873 | NoneBHM A 1 (-4.0A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-4.4A) | 0.83A | 4ltwA-2ax9A:36.1 | 4ltwA-2ax9A:60.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_2 (ANCESTRAL STEROIDRECEPTOR 2) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 8 | MET A 745MET A 787PHE A 876VAL A 889PHE A 891 | BHM A 1 (-3.9A)BHM A 1 (-3.6A)NoneNoneNone | 0.86A | 4ltwA-2ax9A:36.1 | 4ltwA-2ax9A:60.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_2 (ANCESTRAL STEROIDRECEPTOR 2) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 8 | TRP A 741MET A 787PHE A 876VAL A 889PHE A 891 | NoneBHM A 1 (-3.6A)NoneNoneNone | 1.25A | 4ltwA-2ax9A:36.1 | 4ltwA-2ax9A:60.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OJB_A_198A1001_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 11 / 12 | LEU A 707GLY A 708GLN A 711MET A 742MET A 745VAL A 746MET A 749ARG A 752HIS A 874THR A 877MET A 895 | BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)NoneBHM A 1 (-3.0A)None | 0.26A | 4ojbA-2ax9A:42.1 | 4ojbA-2ax9A:99.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OJB_A_198A1001_2 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 7 | LEU A 704ASN A 705MET A 787LEU A 873ILE A 898ILE A 899VAL A 903 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 (-3.6A)BHM A 1 (-4.4A)NoneNoneNone | 0.52A | 4ojbA-2ax9A:42.1 | 4ojbA-2ax9A:99.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OK1_A_198A1001_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 11 / 12 | LEU A 704LEU A 707GLY A 708GLN A 711MET A 742VAL A 746ARG A 752THR A 877MET A 895ILE A 899VAL A 903 | BHM A 1 (-4.0A)BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.6A)BHM A 1 (-3.8A)BHM A 1 (-3.0A)NoneNoneNone | 0.36A | 4ok1A-2ax9A:41.1 | 4ok1A-2ax9A:99.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OK1_A_198A1001_2 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 8 | LEU A 701ASN A 705MET A 745MET A 749MET A 787LEU A 873HIS A 874ILE A 898 | NoneBHM A 1 (-3.6A)BHM A 1 (-3.9A)BHM A 1 (-4.3A)BHM A 1 (-3.6A)BHM A 1 (-4.4A)NoneNone | 0.37A | 4ok1A-2ax9A:41.1 | 4ok1A-2ax9A:99.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKB_A_198A1002_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 11 / 12 | LEU A 707GLY A 708GLN A 711MET A 742MET A 745VAL A 746MET A 749ARG A 752HIS A 874THR A 877ILE A 899 | BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)NoneBHM A 1 (-3.0A)None | 0.45A | 4okbA-2ax9A:41.3 | 4okbA-2ax9A:99.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKB_A_198A1002_2 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 6 | LEU A 704ASN A 705MET A 787LEU A 873MET A 895VAL A 903 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 (-3.6A)BHM A 1 (-4.4A)NoneNone | 0.43A | 4okbA-2ax9A:41.3 | 4okbA-2ax9A:99.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKT_A_198A1001_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 12 / 12 | LEU A 704LEU A 707GLY A 708GLN A 711MET A 742VAL A 746MET A 749ARG A 752MET A 787THR A 877MET A 895ILE A 899 | BHM A 1 (-4.0A)BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.8A)BHM A 1 (-3.6A)BHM A 1 (-3.0A)NoneNone | 0.45A | 4oktA-2ax9A:41.6 | 4oktA-2ax9A:99.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKT_A_198A1001_2 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 4 / 4 | ASN A 705MET A 745LEU A 873HIS A 874 | BHM A 1 (-3.6A)BHM A 1 (-3.9A)BHM A 1 (-4.4A)None | 0.30A | 4oktA-2ax9A:41.6 | 4oktA-2ax9A:99.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKW_A_198A1001_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 12 / 12 | LEU A 707GLY A 708GLN A 711MET A 742MET A 745VAL A 746ARG A 752HIS A 874THR A 877MET A 895ILE A 899VAL A 903 | BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.6A)BHM A 1 (-3.8A)NoneBHM A 1 (-3.0A)NoneNoneNone | 0.42A | 4okwA-2ax9A:41.9 | 4okwA-2ax9A:99.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKW_A_198A1001_2 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 7 | LEU A 704ASN A 705MET A 749MET A 787LEU A 873ILE A 898 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.6A)BHM A 1 (-4.4A)None | 0.39A | 4okwA-2ax9A:41.9 | 4okwA-2ax9A:99.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKX_A_198A1002_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 11 / 12 | LEU A 707GLY A 708GLN A 711MET A 742MET A 745VAL A 746ARG A 752HIS A 874THR A 877MET A 895VAL A 903 | BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.6A)BHM A 1 (-3.8A)NoneBHM A 1 (-3.0A)NoneNone | 0.29A | 4okxA-2ax9A:41.7 | 4okxA-2ax9A:99.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKX_A_198A1002_2 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 6 | LEU A 704ASN A 705MET A 749MET A 787LEU A 873ILE A 899 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.6A)BHM A 1 (-4.4A)None | 0.45A | 4okxA-2ax9A:41.7 | 4okxA-2ax9A:99.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OLM_A_198A1001_1 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 11 / 12 | LEU A 704LEU A 707GLY A 708GLN A 711MET A 742MET A 745VAL A 746ARG A 752HIS A 874THR A 877MET A 895 | BHM A 1 (-4.0A)BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.9A)BHM A 1 (-3.6A)BHM A 1 (-3.8A)NoneBHM A 1 (-3.0A)None | 0.50A | 4olmA-2ax9A:40.0 | 4olmA-2ax9A:99.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OLM_A_198A1001_2 (ANDROGEN RECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 6 | ASN A 705MET A 749MET A 787ILE A 898ILE A 899VAL A 903 | BHM A 1 (-3.6A)BHM A 1 (-4.3A)BHM A 1 (-3.6A)NoneNoneNone | 0.59A | 4olmA-2ax9A:40.0 | 4olmA-2ax9A:99.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704ASN A 705GLY A 708GLN A 711MET A 742ARG A 752 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A) | 0.94A | 4p6xA-2ax9A:32.0 | 4p6xA-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704ASN A 705GLY A 708GLN A 711MET A 742PHE A 891 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)None | 0.93A | 4p6xA-2ax9A:32.0 | 4p6xA-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 704GLN A 711MET A 742ARG A 752GLN A 783 | BHM A 1 (-4.0A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)None | 1.35A | 4p6xA-2ax9A:32.0 | 4p6xA-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_C_HCYC900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 11 | ASN A 705LEU A 707GLN A 711MET A 742ARG A 752 | BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A) | 0.75A | 4p6xC-2ax9A:32.5 | 4p6xC-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_C_HCYC900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 11 | ASN A 705LEU A 707GLN A 711MET A 745ARG A 752 | BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 (-2.2A)BHM A 1 (-3.9A)BHM A 1 (-3.8A) | 1.02A | 4p6xC-2ax9A:32.5 | 4p6xC-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_E_HCYE900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 704ASN A 705GLY A 708GLN A 711MET A 742ARG A 752PHE A 891 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)None | 0.96A | 4p6xE-2ax9A:32.0 | 4p6xE-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_E_HCYE900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704ASN A 705GLY A 708GLN A 711MET A 745ARG A 752 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.9A)BHM A 1 (-3.8A) | 1.02A | 4p6xE-2ax9A:32.0 | 4p6xE-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_E_HCYE900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 704GLN A 711MET A 742ARG A 752GLN A 783 | BHM A 1 (-4.0A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)None | 1.38A | 4p6xE-2ax9A:32.0 | 4p6xE-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_E_HCYE900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 704GLN A 711MET A 745ARG A 752GLN A 783 | BHM A 1 (-4.0A)BHM A 1 (-2.2A)BHM A 1 (-3.9A)BHM A 1 (-3.8A)None | 1.37A | 4p6xE-2ax9A:32.0 | 4p6xE-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | ASN A 705GLY A 708GLN A 711MET A 742ARG A 752PHE A 891 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)None | 0.86A | 4p6xG-2ax9A:32.2 | 4p6xG-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 0.93A | 4p6xG-2ax9A:32.2 | 4p6xG-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLN A 711MET A 742ARG A 752GLN A 783MET A 787 | BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)NoneBHM A 1 (-3.6A) | 1.22A | 4p6xI-2ax9A:32.1 | 4p6xI-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 0.93A | 4p6xI-2ax9A:32.1 | 4p6xI-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704ASN A 705GLY A 708GLN A 711MET A 742ARG A 752 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A) | 0.87A | 4p6xI-2ax9A:32.1 | 4p6xI-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704ASN A 705GLY A 708GLN A 711MET A 742PHE A 891 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)None | 0.92A | 4p6xI-2ax9A:32.1 | 4p6xI-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 704GLN A 711MET A 742ARG A 752GLN A 783 | BHM A 1 (-4.0A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)None | 1.36A | 4p6xI-2ax9A:32.1 | 4p6xI-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | ASN A 705GLY A 708GLN A 711MET A 742ARG A 752PHE A 891 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)None | 0.84A | 4p6xK-2ax9A:32.5 | 4p6xK-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLN A 711MET A 742ARG A 752GLN A 783MET A 787 | BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)NoneBHM A 1 (-3.6A) | 1.24A | 4p6xK-2ax9A:32.5 | 4p6xK-2ax9A:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 0.91A | 4p6xK-2ax9A:32.5 | 4p6xK-2ax9A:49.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R38_B_RBFB201_2 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 4 / 8 | THR A 877VAL A 715LEU A 712MET A 895 | BHM A 1 (-3.0A)NoneNoneNone | 0.91A | 4r38B-2ax9A:undetectable | 4r38B-2ax9A:20.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 701ASN A 705GLN A 711MET A 742ARG A 752MET A 780LEU A 873PHE A 891 | NoneBHM A 1 (-3.6A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-4.4A)None | 0.96A | 4udaA-2ax9A:35.8 | 4udaA-2ax9A:52.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 701GLN A 711MET A 742ARG A 752MET A 780MET A 787LEU A 873 | NoneBHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 ( 4.3A)BHM A 1 (-3.6A)BHM A 1 (-4.4A) | 0.95A | 4udaA-2ax9A:35.8 | 4udaA-2ax9A:52.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711MET A 742ARG A 752MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)BHM A 1 (-3.6A) | 0.90A | 4udcA-2ax9A:32.1 | 4udcA-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704ASN A 705GLY A 708GLN A 711MET A 742ARG A 752 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A) | 0.85A | 4udcA-2ax9A:32.1 | 4udcA-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | LEU A 704ASN A 705GLY A 708GLN A 711PHE A 891 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)None | 0.71A | 4udcA-2ax9A:32.1 | 4udcA-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MWY_A_YNUA1101_0 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 8 / 12 | LEU A 701LEU A 704ASN A 705TRP A 741MET A 742MET A 780MET A 787LEU A 873 | NoneBHM A 1 (-4.0A)BHM A 1 (-3.6A)NoneBHM A 1 ( 4.0A)BHM A 1 ( 4.3A)BHM A 1 (-3.6A)BHM A 1 (-4.4A) | 1.23A | 5mwyA-2ax9A:36.4 | 5mwyA-2ax9A:44.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MWY_A_YNUA1101_1 (MINERALOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 4 / 6 | GLN A 711ARG A 752PHE A 764PHE A 891 | BHM A 1 (-2.2A)BHM A 1 (-3.8A)BHM A 1 (-4.4A)None | 0.54A | 5mwyA-2ax9A:36.4 | 5mwyA-2ax9A:44.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | ARG A 752MET A 780GLN A 783CYH A 784MET A 787 | BHM A 1 (-3.8A)BHM A 1 ( 4.3A)NoneNoneBHM A 1 (-3.6A) | 1.14A | 5nfpA-2ax9A:32.4 | 5nfpA-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | ASN A 705GLY A 708GLN A 711CYH A 784PHE A 891 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)NoneNone | 0.92A | 5nfpA-2ax9A:32.4 | 5nfpA-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | ASN A 705GLY A 708GLN A 711MET A 742ARG A 752CYH A 784 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)None | 0.77A | 5nfpA-2ax9A:32.4 | 5nfpA-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | GLY A 708GLN A 711ARG A 752GLN A 783CYH A 784MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.8A)NoneNoneBHM A 1 (-3.6A) | 1.23A | 5nfpA-2ax9A:32.4 | 5nfpA-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | GLY A 708GLN A 711MET A 742ARG A 752CYH A 784MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 ( 4.0A)BHM A 1 (-3.8A)NoneBHM A 1 (-3.6A) | 0.83A | 5nfpA-2ax9A:32.4 | 5nfpA-2ax9A:46.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 704GLY A 708GLN A 711MET A 745ARG A 752CYH A 784MET A 787 | BHM A 1 (-4.0A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.9A)BHM A 1 (-3.8A)NoneBHM A 1 (-3.6A) | 0.95A | 5uc1A-2ax9A:22.5 | 5uc1A-2ax9A:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 704LEU A 707GLY A 708GLN A 711ARG A 752CYH A 784MET A 787 | BHM A 1 (-4.0A)BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.8A)NoneBHM A 1 (-3.6A) | 0.73A | 5uc1A-2ax9A:22.5 | 5uc1A-2ax9A:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704ASN A 705GLY A 708GLN A 711MET A 745ARG A 752 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.9A)BHM A 1 (-3.8A) | 0.86A | 5uc1B-2ax9A:22.5 | 5uc1B-2ax9A:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704ASN A 705LEU A 707GLY A 708GLN A 711ARG A 752 | BHM A 1 (-4.0A)BHM A 1 (-3.6A)BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.8A) | 0.64A | 5uc1B-2ax9A:22.5 | 5uc1B-2ax9A:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 704GLY A 708GLN A 711MET A 745ARG A 752CYH A 784MET A 787 | BHM A 1 (-4.0A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.9A)BHM A 1 (-3.8A)NoneBHM A 1 (-3.6A) | 0.96A | 5uc1B-2ax9A:22.5 | 5uc1B-2ax9A:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | LEU A 704LEU A 707GLY A 708GLN A 711ARG A 752CYH A 784MET A 787 | BHM A 1 (-4.0A)BHM A 1 ( 4.2A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.8A)NoneBHM A 1 (-3.6A) | 0.75A | 5uc1B-2ax9A:22.5 | 5uc1B-2ax9A:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 7 / 12 | ASN A 705GLY A 708GLN A 711MET A 745ARG A 752PHE A 764LEU A 873 | BHM A 1 (-3.6A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.9A)BHM A 1 (-3.8A)BHM A 1 (-4.4A)BHM A 1 (-4.4A) | 0.75A | 5uc3A-2ax9A:28.6 | 5uc3A-2ax9A:51.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | GLY A 708GLN A 711MET A 745ARG A 752PHE A 764MET A 787 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.9A)BHM A 1 (-3.8A)BHM A 1 (-4.4A)BHM A 1 (-3.6A) | 0.72A | 5uc3A-2ax9A:28.6 | 5uc3A-2ax9A:51.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 708GLN A 711ARG A 752PHE A 764LEU A 873 | BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.8A)BHM A 1 (-4.4A)BHM A 1 (-4.4A) | 0.69A | 5uc3B-2ax9A:28.5 | 5uc3B-2ax9A:51.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) |
2ax9 | ANDROGEN RECEPTOR (Homosapiens) | 6 / 12 | LEU A 704GLY A 708GLN A 711ARG A 752PHE A 764MET A 787 | BHM A 1 (-4.0A)BHM A 1 ( 3.8A)BHM A 1 (-2.2A)BHM A 1 (-3.8A)BHM A 1 (-4.4A)BHM A 1 (-3.6A) | 0.70A | 5uc3B-2ax9A:28.5 | 5uc3B-2ax9A:51.25 |